Seedlabs

RenameLab: Disease Nomenclature Consensus-as-a-Service

A professional service that helps medical groups rename stigmatizing diseases using a rigorous, fair process.

A facilitated, software-backed engagement that packages the PMOS renaming playbook — global surveys, modified Delphi rounds, workshops, marketing analysis — so other medical societies and patient groups can rename stigmatizing or inaccurate conditions with the same rigor.

MedicineOvarian function and disorders
Attention Deficit Hyperactivity DisorderHealthcare governance and communications — consensus research and naming services for medical societies and patient organizations

Concept

A fixed-scope facilitated service, with a software backbone for global stakeholder surveys and Delphi rounds, that lets a medical society or patient organization run the same rigorous renaming process the PMOS consortium just completed: iterative global surveys of patients and multidisciplinary professionals, modified Delphi consensus rounds, nominal-group technique workshops, marketing and linguistic analysis (stigma avoidance, cultural appropriateness across world regions), and a transition-period implementation plan. The deliverable is a consensus new name plus a co-designed rollout strategy, produced with a documented methodology instead of ad-hoc committee debate.

Why now

The paper demonstrates, end-to-end, that this process is feasible at global scale: 56 academic, clinical, and patient organizations engaged; 14,360 respondents from people with the condition and health professionals across all world regions; structured methods (iterative surveys, modified Delphi, nominal group technique); and marketing and implementation analyses that produced both a consensus name and an implementation strategy prioritizing evolution over transformation. Until now, disease renaming efforts have largely been ad hoc and contested; this is the first documented, replicable playbook, and its stated principles — scientific accuracy, clarity, stigma avoidance, cultural appropriateness, implementation feasibility — generalize to the many conditions still carrying inaccurate or stigmatizing names that cause the same delayed-diagnosis and stigma costs the paper describes.

Written by GLM · 3 Oct 2026

AI assessment

Backed by 1 paper82

A niche professional services play that productizes a specific academic methodology for medical nomenclature, though it lacks a scalable software moat.

Evidence strength
5/5
The idea directly mirrors the comprehensive, multi-step methodology detailed in the full text of the PMOS renaming paper.
Market pull
3/5
While medical societies have a need for consensus, the frequency of disease renaming is low, making this a sporadic, project-based revenue stream rather than a recurring market.
Novelty & moat
4/5
It shifts the focus from the specific PMOS transition to a generalizable service for all medical societies, distinguishing it from the existing EHR-focused transition modules.
Feasibility
4/5
The 'playbook' is already written in the research; the MVP is essentially a consultancy backed by survey and Delphi-round software.
Wedge clarity
4/5
The wedge is a fixed-scope 'Renaming Engagement' for a specific society, which is a clear and discrete entry point.
Simplicity / focus
5/5
The product is a single, well-defined service offering with a clear deliverable.

Scored by Gemma 4 · 3 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • Solve ME Initiativeorganization

    The ME/CFS community has long sought a more accurate, less stigmatizing name; a proven, documented global-consensus playbook is exactly the infrastructure that decades of ad-hoc renaming attempts have lacked.

  • IQVIAcompany

    IQVIA runs large-scale global health research; the 14,360-respondent, all-world-region survey logistics and Delphi platform behind this service match its real-world evidence capabilities and could be productized as a new offering.

  • European Society of Human Reproduction and Embryology (ESHRE)organization

    A leading society in reproductive-medicine nomenclature; having watched the PMOS process succeed in its field, it could apply the same playbook to other contested terms in reproductive medicine.

  • American Psychiatric Associationorganization

    DSM terminology carries recurring stigma and accuracy controversies; a rigorous, patient-inclusive renaming methodology would give the APA a defensible, repeatable process for future terminology revisions.

  • World Health Organizationorganization

    WHO must align disease classification (ICD) with evolving condition names; a replicable consensus methodology with built-in cultural appropriateness across world regions directly serves its classification-update mandate.

Research it builds on

  1. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process
    Helena Jane Teede, Mahnaz Bahri Khomami, Rachel Morman et al. · 2026 · 273 citations
    All ideas from this paper →
Leave feedback
feasibility